Annexin V autoantibodies in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 55, Issue 12, 1996, Pages 895-900

  Rodriguez Garcia M I ^a   Fernandez J A ^b   Rodriguez A ^b   Fernandez M P ^a   Gutierrez, C ^b   Torre Alonso, J C ^a,b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUCOCORTICOID; LIPOCORTIN 5;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0030465313     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.12.895     Document Type: Article

References (32)

1. Williams DG. Autoimmunity in rheumatoid arthritis. In: Klippel TH, Dieppe PA, eds. Rheumatology, section 3, chapter 9. London: Mosby Year Book, 1994:1-14.
2. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1994;1197:63-93.
3. Mollenhauer J, Bee JA, Lizarbe MA, von der Mark K. Role of anchorin CII, a 31,000-mol-wt membrane protein, in the interaction of chondrocytes with type II collagen. J Cell Biol 1984; 98:1572-8.
4. Kirsch T, Wuthier RE. Stimulation of calcification of growth plate cartilage matrix vesicles by binding to type-II and type-X collagens. J Biol Chem 1994;269:11462-9.
5. Lee TL, Lin YC, Mochitate K, Grinnell F. Stress-relaxation of fibroblasts in collagen matrices triggers ectocytosis of plasma membrane vesicles containing actin, annexins II and VI, and beta-1 integrin receptors. J Cell Sci 1993;105:167-77.
6. Kim KM, Kim DK, Park YM, Kim CK, Na DS. Annexin I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett 1994;343:251-5.
7. Hirata F, Del Camine R, Nelson CA, Axelrod J, Schiffmann E, Warabi A, et al. Presence of autoantibody for phospholipase inhibitory protein lipomodulin, in patients with rheumatic diseases. Proc Natl Acad Sci USA 1981;78:190-4.
8. Ikai K, Shimizu K, Kanauchi H, Ando Y, Furukawa F, Imamura S. The presence of autoantibody to lipocortin-I in autoimmune-prone mrl mice. Autoimmunity 1992;12:239.
9. Chung KF, Podgorski MR, Goulding NJ, Godolphin JL, Sharland PR, O'Connor B, et al. Circulating autoantibodies to recombinant lipocortin-1 in asthma. Respir Med 1991;85:121-1.
10. Rivers JK, Podgorski MR, Goulding NJ, Wong E, McGrath JA, Flower RJ, et al. The presence of autoantibody to recombinant lipocortin-I in patients with psoriasis and psoriatic arthritis. Br J Dermatol 1990;123:569-72.
11. Matsuda J, Gotoh M, Saitoh N, Gohchi K, Tsukamoto M, Yamamoto T Anti-annexin antibody in the sera of patients with habitual fetal loss or preeclampsia. Thromb Res 1994; 75:105-6.
12. Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto W. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hematol 1994;47:56-8.
13. Pruzanski W, Goulding NJ, Flower RJ, Gladman DD, Urowitz MB, Goodman PJ, et al. Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus - correlative study with disease activity. J Rheumatol 1994;21:252-7.
14. Flower RJ, Rothwell NJ. Lipocortin-1 - cellular mechanisms and clinical relevance. Trends Pharmacol Sci 1994;15:71-6.
15. Goulding NJ, Podgorski MR, Hall ND, Flower RJ, Browning JL, Pepinsky RB, et al. Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1989;48:843-50.
16. Misaki Y, van Venrooij WJ, Pruijn GJM. Prevalence and characteristics of anti-56K/annexin XI autoantibodies in systemic autoimmune diseases. J Rheumatol 1995;22:97-102.
17. Karopoulos C, Rowley MJ, Handley CJ. Intrasynovial levels of sulphated glycosaminoglycans and autoantibodies to type II collagen in rheumatoid arthritis: a correlative analysis. Rheum Int 1993;13:15-20.
18. Arnett FC, Edworthy SM, Bloch DA, Shane DA, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
19. Pinals RS, Masi AT, Larsen RA, The Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for remission in rheumatoid arthritis. Arthritis Rheum 1991; 24:1308-15.
20. Fernandez MP, Morgan RO, Fernandez MR, Carcedo MT. The gene encoding human annexin V has a TATA-less promoter with a high G+C content. Gene 1994;149:253-60.
21. Amann E, Ochs B, Abel K-J. Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli. Gene 1988;69:301-15.
22. Burger A, Berendes R, Voges D, Huber R, Demange P. A rapid and efficient purification method for recombinant annexin V for biophysical studies. FEBS Lett 1993; 329:25-8.
23. Sakata T, Iwagami S, Tsuruta Y, Suzuki S, Suzuki R. Study of natural lipocortin I - a potent mediator for macrophage-mediated immunosuppression in tumorbearing mice. J Immunol 1993;151:4964-72.
24. Peers SH, Smillie F, Elderfield AJ, Flower RJ. Glucocorticoid and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo. Br J Pharmacol 1993;108:66-72.
25. Suarez F, Rothhut B, Cornera C, Touqui L, Marie F R, Silve C. Expression of annexin I, annexin II, annexin V, and annexin VI by rat osteoblasts in primary culture - Stimulation of annexin I expression by dexamethasone. J Bone Miner Res 1993;8:1201-10.
26. Fernandez M P, Fernandez M R, Morgan R O. Structure of the gene encoding anchorin CII (chick annexin V). Gene 1994; 141: 179-186.
27. Kovacic RT, Tizard R, Cate RL, Frey AZ, Wallner BP. Correlation of gene and protein structure of rat and human lipocortin I. Biochemistry 1991;30:9015-21.
28. Podgorski MR, Goulding NJ, Hall ND, Flower RJ, Maddison PJ. Autoantibodies to lipocortin-1 are associated with impaired glucocorticoid responsiveness in rheumatoid arthritis. J Rheumatol 1992;19:1668-71.
29. Morand EF, Jefferiss CM, Dixey J, Mitra D, Goulding NJ. Impaired glucocorticoid induction of mononuclear leukocyte lipocortin-1 in rheumatoid arthritis. Arthritis Rheum 1994;37:207-11.
30. Goulding NJ, Guyre PM. Lipocortin 1 binding to human leukocytes correlates with its ability to inhibit IgG interactions with Fc gamma receptors. Biochem Biophys Res Commun 1993;192:351-8.
31. Kristoffersen EK, Ulvestad E, Bjorge L, Aarli A, Matre R. Fc-gamma-receptor activity of placental annexin II. Scand J Immunol 1994;40:237-42.
32. Dubois T, Bisagni-Faure A, Coste J, Mavoungou E, Menkes C J, Russo-Marie F, et al. High levels of antibodies to annexins V and VI in patients with rheumatoid arthritis. J Rheumatol 1995;22:1230-4.